NDTP — NDT Pharmaceuticals Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $14.48m
- $14.42m
Annual cashflow statement for NDT Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2007 December 31st | 2008 December 31st | R2009 December 31st | 2010 December 31st | 2011 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | ARS | ARS | ARS | ARS |
Standards: | USG | — | — | — | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -1.04 | -0.052 | -1.04 | -0.246 | -0.031 |
Non-Cash Items | 0.985 | 0.017 | 1 | 0.189 | — |
Other Non-Cash Items | |||||
Changes in Working Capital | 0.013 | 0.004 | -0.291 | 0.043 | -1.02 |
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -0.039 | -0.031 | -0.326 | -0.015 | -1.05 |
Financing Cash Flow Items | 1 | 0 | — | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -0.03 | 0.1 | 0.322 | 0.019 | 1.23 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.07 | 0.069 | -0.005 | 0.005 | 0.181 |